India to Peru: Sunitinib Export Trade Route
India has recorded 30 verified shipments of Sunitinib exported to Peru, representing a combined trade value of $1.6M USD. This corridor is served by 6 active Indian exporters, with an average shipment value of $53.5K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED , which accounts for 52% of total export value with 6 shipments worth $838.1K USD. On the buying side, SUN PHARMACEUTICAL INDUSTRIES is the largest importer in Peru with $838.1K USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED , MSN LABORATORIES PRIVATE LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED — together control 95% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Peru Sunitinib corridor is one of India's established pharmaceutical export routes, with 30 shipments documented worth a combined $1.6M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED , which alone accounts for roughly 52% of all export value, reflecting the consolidated nature of India's sunitinib manufacturing sector.
Across 6 active suppliers, the average shipment value stands at $53.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with sunitinib's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 22 days port-to-port. The route has recorded an annual growth rate of 18.9%, placing it at rank #19 among India's top sunitinib export destinations globally.
On the import side, key buyers of Indian sunitinib in Peru include SUN PHARMACEUTICAL INDUSTRIES , MSN LABS PERU SAC, TO THE ORDER OF and 5 others. SUN PHARMACEUTICAL INDUSTRIES is the single largest importer with 6 shipments valued at $838.1K USD.
Route Characteristics
- Average transit22 days
- Peak seasonQ1
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#19
- Annual growth+18.9%
- Demand growth+18.0%
- Regulatory ease87/100
Top 10 Indian Sunitinib Exporters to Peru
Showing top 10 of 6 Indian suppliers exporting Sunitinib to Peru, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $139.7K per shipment | 6 | $838.1K | 52.3% |
| 2 | MSN LABORATORIES PRIVATE LIMITED Avg $99.2K per shipment | 5 | $496.0K | 30.9% |
| 3 | BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED Avg $12.3K per shipment | 16 | $197.2K | 12.3% |
| 4 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $72.2K per shipment | 1 | $72.2K | 4.5% |
| 5 | NIBA HEALTHCARE Avg $238 per shipment | 1 | $238 | 0.0% |
| 6 | R L PHARMA Avg $235 per shipment | 1 | $235 | 0.0% |
This table shows the top 10 of 6 Indian companies exporting sunitinib to Peru, ranked by total trade value. The listed exporters are: SUN PHARMACEUTICAL INDUSTRIES LIMITED , MSN LABORATORIES PRIVATE LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, NIBA HEALTHCARE, R L PHARMA. SUN PHARMACEUTICAL INDUSTRIES LIMITED is the dominant supplier with 6 shipments worth $838.1K USD, giving it a 52% market share. The top 3 suppliers together account for 95% of the total trade value on this route.
Top 10 Sunitinib Importers in Peru
Showing top 10 of 8 known buyers in Peru receiving Sunitinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian sunitinib in Peru include SUN PHARMACEUTICAL INDUSTRIES , MSN LABS PERU SAC, TO THE ORDER OF, DIDRSASR, SUN PHARMACEUTICAL INDUSTRIES, among 8 total buyers. The largest importer is SUN PHARMACEUTICAL INDUSTRIES , accounting for $838.1K USD across 6 shipments — representing 52% of all sunitinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES | 6 | $838.1K | 52.3% |
| 2 | MSN LABS PERU SAC | 4 | $279.9K | 17.5% |
| 3 | TO THE ORDER OF | 1 | $216.0K | 13.5% |
| 4 | DIDRSASR | 12 | $157.5K | 9.8% |
| 5 | SUN PHARMACEUTICAL INDUSTRIES | 1 | $72.2K | 4.5% |
| 6 | DIDRSASR DISTRIBUIDORA DROGUERIA SAGITARIO SRL | 4 | $39.6K | 2.5% |
| 7 | ADRIAN MANUEL ROBERTO RODRIGUEZ ORT EGA ID | 1 | $238 | 0.0% |
| 8 | MANUEL ROBERTO RODRGUEZ ORTEGA | 1 | $235 | 0.0% |
Top 10 Sunitinib Formulations Imported by Peru
Showing top 10 of 25 product formulations shipped on the India to Peru Sunitinib route, ranked by trade value
Peru imports a wide range of sunitinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — SUNITIN CAP 25MG (SUNITINIB MALATE CAPSU — accounts for $838.1K USD across 6 shipments. There are 25 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SUNITIN CAP 25MG (SUNITINIB MALATE CAPSU | 6 | $838.1K | 52.3% |
| 2 | SUTYKA 25MG (SUNITINIB 2X14 S) MSN -PE | 1 | $216.0K | 13.5% |
| 3 | SUTYAKA 25 MG (SUNITINIB 2X14"S)MSN ( QTY: 2033 PAC AS PER INVOICE ) | 1 | $120.7K | 7.5% |
| 4 | Sutkya 25 mg (Sunitinib 2x14's) MSN-PE BATCH NO:CRE11042A | 1 | $94.8K | 5.9% |
| 5 | SUNITINIB 25MG (DOXETIN) (TAX INVMH1160 | 1 | $87.2K | 5.4% |
| 6 | SUNITIN CAP 25MG (SUNITINIB MALATE CAPSU | 1 | $72.2K | 4.5% |
| 7 | SUTYKA 25MGSUNITINIB 2x14's MSN -PE | 1 | $52.3K | 3.3% |
| 8 | SUNITINIB 25MG DOXETIN TAX INVMH1160000341 DT23.10.2023 | 1 | $39.6K | 2.5% |
| 9 | SUNITINIB 25MG (DOXETIN) (OTHER)(TAX INV# MH1160000634 DT:21.03.2024) | 1 | $28.0K | 1.7% |
| 10 | SUNITINIB 25 MG (DOXETIN) (OTHER) (TAX INV# MH2411600061 DT: 13.05.2024) | 1 | $23.7K | 1.5% |
Showing top 10 of 25 Sunitinib formulations imported by Peru on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 82%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 14 shipments. Transit time averages 22 days by sea.
Market Dynamics
India's sunitinib exports to Peru are driven primarily by a handful of large-scale manufacturers. SUN PHARMACEUTICAL INDUSTRIES LIMITED with 6 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Peru benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED , MSN LABORATORIES PRIVATE LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED — together account for 95% of total trade value on this route. The average shipment value of $53.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as sutyka 25mg (sunitinib 2x14 s) msn -pe and sutyaka 25 mg (sunitinib 2x14"s)msn ( qty: 2033 pac as per invoice ), suggesting that buyers in Peru tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, SUN PHARMACEUTICAL INDUSTRIES is the largest importer with 6 shipments worth $838.1K USD — representing 52% of all sunitinib imports from India on this route. A total of 8 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $1.6M
- Avg. Shipment
- $53.5K
- Suppliers
- 6
- Buyers
- 8
- Transit (Sea)
- ~22 days
- Annual Growth
- +18.9%
Other Sunitinib Routes
Unlock the Full India to Peru Sunitinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 30 shipments on this route.
Frequently Asked Questions — India to Peru Sunitinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Sunitinib to Peru?
The leading Indian exporters of Sunitinib to Peru are SUN PHARMACEUTICAL INDUSTRIES LIMITED , MSN LABORATORIES PRIVATE LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED. SUN PHARMACEUTICAL INDUSTRIES LIMITED holds the largest market share at approximately 52% of total trade value on this route.
Q What is the total value of Sunitinib exports from India to Peru?
India exports Sunitinib to Peru worth approximately $1.6M USD across 30 recorded shipments. The average value per shipment is $53.5K USD.
Q Which ports does India use to ship Sunitinib to Peru?
The most active port of origin is SAHAR AIR with 14 shipments. Indian exporters primarily use sea freight for this route, with 82% of shipments going by sea and 28% by air.
Q How long does shipping take from India to Peru for Sunitinib?
The average transit time for Sunitinib shipments from India to Peru is approximately 22 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Peru Sunitinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 18.9% with demand growth tracking at 18.0%. The route is ranked #19 among India's top Sunitinib export destinations globally.
Q How many suppliers are active on the India to Peru Sunitinib route?
There are currently 6 active Indian suppliers exporting Sunitinib to Peru. The market is moderately concentrated with SUN PHARMACEUTICAL INDUSTRIES LIMITED accounting for 52% of total shipment value.
Q Who are the main importers of Sunitinib from India in Peru?
The leading importers of Indian Sunitinib in Peru include SUN PHARMACEUTICAL INDUSTRIES , MSN LABS PERU SAC, TO THE ORDER OF, DIDRSASR, SUN PHARMACEUTICAL INDUSTRIES. SUN PHARMACEUTICAL INDUSTRIES is the largest buyer with 6 shipments worth $838.1K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Peru export trade corridor identified from Indian Customs (DGFT) records for Sunitinib.
- 2.Supplier/Buyer Matching: 6 Indian exporters and 8 importers in Peru matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 30 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
30 Verified Shipments
6 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists